Hilga Katerberg
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Hilga Katerberg has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
Danielle C. Cath
Department of Psychiatry, VU University Medical Center, Amsterdam, The Netherlands
3 shared publicationsJohan A. Den Boer
Department of Psychiatry, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
3 shared publications- Peter Heutink
Institute of Neurogenetics, University of Luebeck, Luebeck, Germany
3 shared publications Annemiek Polman
Department of Psychiatry, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
2 shared publicationsAnton J.L.M. van Balkom
Department of Psychiatry, VU University Medical Center, Amsterdam, The Netherlands
2 shared publicationsZoltán Bochdanovits
Department of Clinical Genetics, Section Medical Genomics, VU University Medical Center, Amsterdam, the Netherlands
2 shared publications
Latest Publications
- 21 December 2009
- Published by Wiley in American Journal of Medical Genetics Part B: Neuropsychiatric Genetics
- Vol. 153B (1) , 167-176
The role of the COMT Val158Met polymorphism in the phenotypic expression of obsessive‐compulsive disorder
Obsessive‐Compulsive Disorder (OCD) is characterized by the presence of obsessions and compulsions, and shows considerable phenotypic variability. Family and twin studies have indicated a genetic component in the etiology of OCD, and the catechol‐O‐methyl transferase (COMT) gene is an important candidate gene for OCD. This study investigates the influence of the functional COMT Val158Met polymorphism on the phenotypic expression of OCD, using an item‐level factor‐analytic approach in a large sample. The COMT Val158Met variant was genotyped in 373 patients and 462 controls. It was tested whether there was an association between the COMT Val158Met polymorphism and OCD or dimensional phenotypes such as YBOCS severity score, age of onset of obsessive‐compulsive symptoms and six symptom dimensions recently found in a large item‐level factor‐analytic study [Katerberg et al., submitted]. We further investigated possible sex‐specific associations between the COMT Val158Met polymorphism and OCD or dimensional phenotypes. There was a trend for an association of the COMT 158Met allele with OCD in males, and an interaction between the COMT Val158Met genotype and sex on the somatic and sensory phenomena symptom dimension, with females showing lower scores. In conclusion, a dimensional approach seems fruitful in detecting genes of importance for OCD.
- 21 December 2009
- Published by Wiley in American Journal of Medical Genetics Part B: Neuropsychiatric Genetics
- Vol. 153B (1) , 167-176
The role of the COMT Val158Met polymorphism in the phenotypic expression of obsessive‐compulsive disorder
Obsessive‐Compulsive Disorder (OCD) is characterized by the presence of obsessions and compulsions, and shows considerable phenotypic variability. Family and twin studies have indicated a genetic component in the etiology of OCD, and the catechol‐O‐methyl transferase (COMT) gene is an important candidate gene for OCD. This study investigates the influence of the functional COMT Val158Met polymorphism on the phenotypic expression of OCD, using an item‐level factor‐analytic approach in a large sample. The COMT Val158Met variant was genotyped in 373 patients and 462 controls. It was tested whether there was an association between the COMT Val158Met polymorphism and OCD or dimensional phenotypes such as YBOCS severity score, age of onset of obsessive‐compulsive symptoms and six symptom dimensions recently found in a large item‐level factor‐analytic study [Katerberg et al., submitted]. We further investigated possible sex‐specific associations between the COMT Val158Met polymorphism and OCD or dimensional phenotypes. There was a trend for an association of the COMT 158Met allele with OCD in males, and an interaction between the COMT Val158Met genotype and sex on the somatic and sensory phenomena symptom dimension, with females showing lower scores. In conclusion, a dimensional approach seems fruitful in detecting genes of importance for OCD.
- 13 February 2009
- Published by Wiley in American Journal of Medical Genetics Part B: Neuropsychiatric Genetics
- Vol. 150B (8) , 1050-1062
The role of the brain‐derived neurotrophic factor (BDNF) val66met variant in the phenotypic expression of obsessive‐compulsive disorder (OCD)
Evidence suggests that the Val66Met variant of the brain‐derived neurotrophic factor (BDNF) gene may play a role in the etiology of Obsessive‐Compulsive Disorder (OCD). In this study, the role of the BDNF Val66Met variant in the etiology and the phenotypic expression of OCD is investigated. Associations between the BDNF Val66Met variant and OCD, obsessive‐compulsive symptom dimensions, Yale‐Brown Obsessive Compulsive Scale (YBOCS) severity scores, age of onset and family history of obsessive‐compulsive symptoms were assessed. The BDNF Val66Met variant was genotyped in 419 patients with sub‐/clinical OCD and 650 controls. No differences in allele or genotype frequency were observed between cases and controls. In females with OCD, the Met66Met genotype was associated with later age of onset and a trend for a negative family history, whereas the Val66Val genotype was associated with a trend for lower YBOCS severity scores. Item‐level factor analysis revealed six factors: 1) Contamination/cleaning; 2) Aggressive obsessions/checking; 3) Symmetry obsessions, counting, ordering and repeating; 4) Sexual/religious obsessions; 5) Hoarding and 6) Somatic obsessions/checking. A trend was found for a positive association between Factor 4 (Sexual/religious obsessions) and the BDNF Val66Val genotype. The results suggest that BDNF function may be implicated in the mediation of OCD. We found that for the BDNF Met66Met genotype may be associated with a milder phenotype in females and a possible role for the BDNF Val66Val genotype and the BDNF Val66 allele in the sexual/religious obsessions.
- 13 February 2009
- Published by Wiley in American Journal of Medical Genetics Part B: Neuropsychiatric Genetics
- Vol. 150B (8) , 1050-1062
The role of the brain‐derived neurotrophic factor (BDNF) val66met variant in the phenotypic expression of obsessive‐compulsive disorder (OCD)
Evidence suggests that the Val66Met variant of the brain‐derived neurotrophic factor (BDNF) gene may play a role in the etiology of Obsessive‐Compulsive Disorder (OCD). In this study, the role of the BDNF Val66Met variant in the etiology and the phenotypic expression of OCD is investigated. Associations between the BDNF Val66Met variant and OCD, obsessive‐compulsive symptom dimensions, Yale‐Brown Obsessive Compulsive Scale (YBOCS) severity scores, age of onset and family history of obsessive‐compulsive symptoms were assessed. The BDNF Val66Met variant was genotyped in 419 patients with sub‐/clinical OCD and 650 controls. No differences in allele or genotype frequency were observed between cases and controls. In females with OCD, the Met66Met genotype was associated with later age of onset and a trend for a negative family history, whereas the Val66Val genotype was associated with a trend for lower YBOCS severity scores. Item‐level factor analysis revealed six factors: 1) Contamination/cleaning; 2) Aggressive obsessions/checking; 3) Symmetry obsessions, counting, ordering and repeating; 4) Sexual/religious obsessions; 5) Hoarding and 6) Somatic obsessions/checking. A trend was found for a positive association between Factor 4 (Sexual/religious obsessions) and the BDNF Val66Val genotype. The results suggest that BDNF function may be implicated in the mediation of OCD. We found that for the BDNF Met66Met genotype may be associated with a milder phenotype in females and a possible role for the BDNF Val66Val genotype and the BDNF Val66 allele in the sexual/religious obsessions.
- 1 April 2008
- Published by Wolters Kluwer Health in Psychiatric Genetics
- Vol. 18 (2) , 98
Screening of the epsilon sarcoglycan gene in Tourette syndrome and obsessive compulsive disorder
- 1 April 2008
- Published by Wolters Kluwer Health in Psychiatric Genetics
- Vol. 18 (2) , 98
Screening of the epsilon sarcoglycan gene in Tourette syndrome and obsessive compulsive disorder